Melatonin Agonist Tasimelteon (VEC-162) for Transient Insomnia After Sleep-Time Shift: Two Randomized Controlled Multicentre Trials.
Page: 604DOI: 10.1097/01.ogx.0000358014.55641.1cAuthors: Rajaratnam, Shantha M.W.; Polymeropoulos, Mihael H.; Fisher, Dennis M.; Roth, Thomas; Scott, Christin; Birznieks, Gunther; Klerman, Elizabeth B. (Source: Obstetrical & Gynecological Survey)
MedWorm Message: Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
Related posts:
- Melatonin Synergizes With Oxytocin to Enhance Contractility of Human Myometrial Smooth Muscle Cells.
- Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety
- Melatonin May Be Safe, Effective for Sleep-onset Insomnia in Children With ADHD
- Placebo-controlled study of agomelatine in major depressive disorder
- Melatonin for primary insomnia
Related Posts
You must be logged in to post a comment.